Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Human Molecular Genetics
|
March 15, 2023
Human calmodulin mutations cause arrhythmia and affect neuronal function in C. elegans
Helene H Jensen, Magnus T Frantzen, Jonas L Wesseltoft, et al.
G3 (Bethesda, Md.)
|
May 2, 2024
CED-6/GULP and components of the clathrin-mediated endocytosis machinery act redundantly to correctly display CED-1 on the cell membrane in Caenorhabditis elegans
Rikke Hindsgaul Harders, Tine H Morthorst, Line E Landgrebe, et al.
Scientific Reports
|
May 22, 2021
The TGF-β ligand DBL-1 is a key player in a multifaceted probiotic protection against MRSA in C. elegans
Maria G M Mørch, Katrine V Møller, Marianne O Hesselager, et al.
Journal of Immunotherapy and Precision Oncology
|
January 15, 2025
Real-World Outcomes in Patients with Advanced Penile Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Single Institution Experience
Tony Z Zhuang, Subir Goyal, Katherine B Case, et al.
EMBO Reports
|
March 31, 2018
Alpha-synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation
Cristine Betzer, Louise Berkhoudt Lassen, Anders Olsen, et al.
Translational Psychiatry
|
November 22, 2025
Functional consequences of calmodulin variants identified among schizophrenia patients and controls
Helene Halkjær Jensen, Malene Brohus, John W Hussey, et al.
Journal of Immunotherapy and Precision Oncology
|
August 29, 2022
Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience
Dylan J Martini, T Anders Olsen, Subir Goyal, et al.
Frontiers in Oncology
|
July 5, 2021
Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade
T Anders Olsen, Dylan J Martini, Subir Goyal, et al.
Frontiers in Oncology
|
July 26, 2021
Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
Dylan J Martini, T Anders Olsen, Subir Goyal, et al.
Clinical Genitourinary Cancer
|
December 19, 2021
Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients
Dylan J Martini, Sean T Evans, Yuan Liu, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Human Molecular Genetics
|
March 15, 2023
Human calmodulin mutations cause arrhythmia and affect neuronal function in C. elegans
Helene H Jensen, Magnus T Frantzen, Jonas L Wesseltoft, et al.
G3 (Bethesda, Md.)
|
May 2, 2024
CED-6/GULP and components of the clathrin-mediated endocytosis machinery act redundantly to correctly display CED-1 on the cell membrane in Caenorhabditis elegans
Rikke Hindsgaul Harders, Tine H Morthorst, Line E Landgrebe, et al.
Scientific Reports
|
May 22, 2021
The TGF-β ligand DBL-1 is a key player in a multifaceted probiotic protection against MRSA in C. elegans
Maria G M Mørch, Katrine V Møller, Marianne O Hesselager, et al.
Journal of Immunotherapy and Precision Oncology
|
January 15, 2025
Real-World Outcomes in Patients with Advanced Penile Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Single Institution Experience
Tony Z Zhuang, Subir Goyal, Katherine B Case, et al.
EMBO Reports
|
March 31, 2018
Alpha-synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation
Cristine Betzer, Louise Berkhoudt Lassen, Anders Olsen, et al.
Translational Psychiatry
|
November 22, 2025
Functional consequences of calmodulin variants identified among schizophrenia patients and controls
Helene Halkjær Jensen, Malene Brohus, John W Hussey, et al.
Journal of Immunotherapy and Precision Oncology
|
August 29, 2022
Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience
Dylan J Martini, T Anders Olsen, Subir Goyal, et al.
Frontiers in Oncology
|
July 5, 2021
Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade
T Anders Olsen, Dylan J Martini, Subir Goyal, et al.
Frontiers in Oncology
|
July 26, 2021
Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
Dylan J Martini, T Anders Olsen, Subir Goyal, et al.
Clinical Genitourinary Cancer
|
December 19, 2021
Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients
Dylan J Martini, Sean T Evans, Yuan Liu, et al.
Page
of 5